76
Participants
Start Date
June 30, 2001
Primary Completion Date
April 26, 2013
Study Completion Date
February 13, 2017
Vincristine
1.4 mg/m² intravenously (IV) on week 2, 4, 6, 8
Cyclophosphamide
650 mg/m², on week 1 and 5
Doxorubicin
25 mg/m², on week 1, 3, 5, 7
Prednisone
40 mg/m², oral, every other day. Taper-reduction 10 mg/m² every other day during last 2 weeks of chemotherapy
Bleomycin
5 u/m² intravenously (IV) on week 2, 4, 6, 8
Etoposide
60 mg/m² x 2 intravenously (IV) on week 3, 7 (d 15, 16, 43, 44)
Low-dose radiotherapy (RT)
20 Grey (Gy) modified involved field radiotherapy administered as consolidative irradiation will beginning between 2 and 12 weeks after the completion of Stanford V-C chemotherapy regimen.
Stanford University School of Medicine, Stanford
Kaiser Permanente Medical Center, Vallejo
Stanford University
OTHER